SRISID LLC Increases Position to 7.55M Shares of ConnectM, Representing 15.1% of the Company's Outstanding Common Stock

Stock Information for Revive Therapeutics Ltd

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Revive Therapeutics Ltd

ConnectM Reduces Over $8.35 Million of Convertible Debt, Adds New Capital Partners and Highlights Strategic Acquisitions of Amperics and Geo Impex
ConnectM's Keen Labs Introduces Hi-C(TM) Hybrid Energy Storage Line for High-Power Applications
ConnectM Releases 2025 Annual Shareholder Letter Highlighting Turnaround From $50 Million Deficit to Positive Equity
ConnectM Announces $35 Million Annual Organic Revenue Run Rate and Returns to Positive Stockholders' Equity
ConnectM Delivers on Turnaround Plan: Back to OTCQB and Aiming for National Exchange Uplisting
ConnectM, Keen Labs and Star Engineers Launch StarConnectM LLP to Accelerate AI-Powered Connected Vehicle Platforms
ConnectM Reports Third Quarter 2025 Results: 45% Revenue Growth and Continued Balance Sheet Deleveraging
ConnectM Signs $1.7 Million Distribution Agreement with Greentech Renewables to Scale Keen Smart Heat Pump Technology

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.